Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 275

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 275
---
 approved the 2024 Plan and 2024 ESPP, with an initial reserve of 51,726 and 5,272 shares of common stock,         
 respectively. The 2024 Plan and 2024 ESPP became effective on February 14, 2024 in connection with the closing of the Business Combination. 
 At a special meeting of stockholders on April 30, 2024, the stockholders approved an increase in the number of shares available for         
 issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock options, by an additional 20,000       
 shares each. At a special meeting of stockholders on November 11, 2024, the stockholders approved an increase in the number of shares       
 available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock options, by an           
 additional 208,454 shares each. As of January 8, 2025, no awards have been granted under the 2024 ESPP. No new awards may be granted        
 under the 2016 Plan, but all outstanding awards under the 2016 Plan continue to be governed by their existing terms. The 2024 Plan          
 has an evergreen provision that allows for an annual increase in the number of shares available for issuance under the 2024 Plan            
 to be added on the first day of January, starting with January 1, 2025, in an amount equal to the lesser of (i) 5% of the fully diluted     
 shares of our common stock on the immediately preceding December 31 or (ii) such number of shares as determined by our board in each        
 case subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. On January 1, 2025,         
 the number of shares reserved under the 2024 Plan was increased by 5% of the fully diluted shares of our common stock on the immediately    
 preceding December 31, or 189,701 shares. The 2024 ESPP has an evergreen provision that allows for an annual increase in the number         
 of shares available for issuance under the 2024 ESPP to be added on the first day of each January, starting with January 1, 2024,           
 by the lesser of (i) 10,198 shares of our common stock, (ii) 1% of the fully diluted shares of common stock on the immediately preceding